(GlobeNewswire) - Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that on March 29, 2018 the …
The stock has more than tripled in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DVAX …
Dynavax Technologies Corporation (NASDAQ:DVAX) opened Monday with a 27% jump from Friday’s close. The surge in DVAX stock comes on the heels of updated results from its ongoing Phase 1b/2 clinical trial of its toll-like receptor 9 …
If you are looking to invest in Dynavax Technologies Corporation’s (NASDAQ:DVAX), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. Every stock in the market …
A total of 54,747,656 shares of the Company s common stock were entitled to ... which are in the preclinical stage. The …
Investors in Dynavax Technologies Corporation DVAX need to pay close attention to the stock based on moves in the options market lately. That is because the August 18 th, 2017 $10 Call had some of the highest implied volatility of all …
Investors in Dynavax Technologies Corporation DVAX need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 17, 2017 $15 Put had some of the highest implied volatility of all equity …